|
|
Volumn 317, Issue 16, 2017, Pages 1611-1613
|
|
Medical Marijuana is legal in most states, but physicians have little evidence to guide them
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANNABIDIOL;
CANNABINOID;
MEDICAL CANNABIS;
TETRAHYDROCANNABINOL;
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
CHRONIC PAIN;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG INDICATION;
DRUG LEGISLATION;
DRUG MISUSE;
DRUG RESEARCH;
DRUG USE;
EVIDENCE BASED MEDICINE;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ACCESS;
HUMAN;
MEDICAL EDUCATION;
MEDICAL PRACTICE;
MEDICAL SCHOOL;
MEDICAL SOCIETY;
MULTIPLE SCLEROSIS;
MUSCLE SPASM;
NONHUMAN;
PATIENT CARE;
PRACTICE GUIDELINE;
PRESCRIPTION;
PROFESSIONAL KNOWLEDGE;
REVIEW;
SYMPTOM;
THERAPY EFFECT;
TREATMENT RESPONSE;
UNITED STATES;
ATTITUDE TO HEALTH;
PHYSICIAN;
EDUCATION, MEDICAL, CONTINUING;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
MEDICAL MARIJUANA;
PHYSICIANS;
PRACTICE GUIDELINES AS TOPIC;
UNITED STATES;
|
|
EID: 85018294438
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2017.0813 Document Type: Review |
|
Times cited : (21)
|
|
References (0)
|
